ARGENX SE is 27.6x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($53.35 B vs $1.94 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADMA | ARGX |
|---|---|---|
| Market cap | $1.94 B | $53.35 B |
| US-listed rank | #2129 | #306 |
| Revenue (latest FY) | $510.17M | - |
| Net income (latest FY) | $146.93M | - |
| Net margin | 28.8% | - |
| P/E (trailing FY) | 13.2 | - |
| SEC filings | 988 | 272 |
ARGENX SE is 27.6x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($53.35 B vs $1.94 B).
Full pages: ADMA BIOLOGICS, INC. and ARGENX SE, or browse the full rankings.